London: British pharma giant AstraZeneca is contemplating combining its COVID-19 vaccine with Russian Sputnik V vaccine in a bid to increase efficacy.
AstraZeneca said on Friday it will be assessing combinations of their vaccine with the one developed by Russia’s Gamaleya Institute.
Both vaccines are based on the common cold virus.
“Current full dose AstraZeneca regimen resulted in 62% efficacy. If they go for a new clinical trial, we suggest trying a regimen of combining the AZ shot with the #SputnikV human adenoviral vector shot to boost efficacy. Combining vaccines may prove important for revaccinations,” the developers of Sputnik V had said last month.
The Oxford-AstraZeneca vaccine has an average efficacy of 70.4 per cent, while Russia has claimed a 92 per cent effectiveness for its Sputnik V.
Also Read: Govt Likely To Get Oxford COVID Vaccine In January-February
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
This website uses cookies.